{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:30:56Z","timestamp":1793615456404,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Leishmaniasis is a vector-borne parasitic disease caused by protozoa of the\n                      <jats:italic>Leishmania<\/jats:italic>\n                      genus; it is transmitted through the bites of infected phlebotomine sandflies. Clinically, it manifests in three primary forms: cutaneous, mucocutaneous, and visceral leishmaniasis (VL). Among these, VL represents the most severe form, characterized by high morbidity and mortality, and poses a considerable public health burden, particularly in endemic regions. This study utilizes data from the Global Burden of Disease (GBD) study 2021 to conduct a comprehensive analysis of the global epidemiological trends and burden of VL from 1990 to 2021, aiming to generate evidence-based insights to inform prevention and control strategies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using GBD 2021 data, this study examined trends in the incidence, prevalence, mortality, and disability-adjusted life years (DALYs) of VL across 204 countries and territories, stratified by age, sex, and sociodemographic index (SDI) levels. Average annual percent change (AAPC) was calculated to describe trends in age-standardized rates and indicator counts from 1990 to 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 1990 to 2021, the global age-standardized incidence rate (ASIR; AAPC\u2009=\u2009\u22120.25, 95% confidence interval (CI) \u22120.25, \u22120.24), age-standardized prevalence rate (ASPR; AAPC\u2009=\u2009\u22120.06, 95% CI \u22120.06, \u22120.05), age-standardized mortality rate (ASMR; AAPC\u2009=\u2009\u22120.03, 95% CI \u22120.04, \u22120.02), and DALY rate (AAPC\u2009=\u2009\u22122.38, 95% CI \u22122.44, \u22122.33) for VL all showed a declining trend. The ASMR was highest among children under 5\u00a0years old and decreased progressively with age. VL remains a critical and under-recognized tropical disease in Latin America, the Middle East, Africa, and South Asia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>VL disproportionately affects males and presents the highest risk in children under 5\u00a0years. Enhanced global collaboration in infectious disease control, with a focus on regions such as Latin America, Africa, the Middle East, and South Asia, is essential to further reduce the burden of VL.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-025-06796-x","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T06:38:12Z","timestamp":1745649492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Global, regional, and national burden of visceral leishmaniasis, 1990\u20132021: findings from the global burden of disease study 2021"],"prefix":"10.1186","volume":"18","author":[{"given":"Shun-Xian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Yong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"key":"6796_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006697","volume":"12","author":"JMT Bezerra","year":"2018","unstructured":"Bezerra JMT, de Ara\u00fajo VEM, Barbosa DS, Martins-Melo FR, Werneck GL, Carneiro M. Burden of leishmaniasis in Brazil and federated units, 1990\u20132016: findings from global burden of disease study 2016. PLoS Negl Trop Dis. 2018;12:e0006697. https:\/\/doi.org\/10.1371\/journal.pntd.0006697.","journal-title":"PLoS Negl Trop Dis"},{"key":"6796_CR2","doi-asserted-by":"publisher","first-page":"928","DOI":"10.4269\/ajtmh.24-0036","volume":"111","author":"A Mewara","year":"2024","unstructured":"Mewara A, Satapathy P, Dhatwalia SK. Visceral leishmaniasis in Sub-Himalayan India (1967\u20132023): a systematic review. Am J Trop Med Hyg. 2024;111:928\u201333. https:\/\/doi.org\/10.4269\/ajtmh.24-0036.","journal-title":"Am J Trop Med Hyg"},{"key":"6796_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40249-025-01274-z","volume":"14","author":"AGS Duarte","year":"2025","unstructured":"Duarte AGS, Werneck GL, de Farias Lelis S, Mendon\u00e7a TS, Vasconcelos DD, Gontijo TS, et\u00a0al. An updated systematic review with meta-analysis and meta-regression of the factors associated with human visceral leishmaniasis in the Americas. Infect Dis Poverty. 2025;14:4. https:\/\/doi.org\/10.1186\/s40249-025-01274-z.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR4","doi-asserted-by":"publisher","first-page":"1488741","DOI":"10.3389\/fpubh.2024.1488741","volume":"12","author":"AK Geto","year":"2024","unstructured":"Geto AK, Berihun G, Berhanu L, Desye B, Daba C. Prevalence of human visceral leishmaniasis and its risk factors in Eastern Africa: a systematic review and meta-analysis. Front Public Health. 2024;12:1488741. https:\/\/doi.org\/10.3389\/fpubh.2024.1488741.","journal-title":"Front Public Health"},{"key":"6796_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.idc.2018.10.005","volume":"33","author":"J van Griensven","year":"2019","unstructured":"van Griensven J, Diro E. Visceral leishmaniasis: recent advances in diagnostics and treatment regimens. Infect Dis Clin North Am. 2019;33:79\u201399. https:\/\/doi.org\/10.1016\/j.idc.2018.10.005.","journal-title":"Infect Dis Clin North Am"},{"key":"6796_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005231","volume":"11","author":"T Sunyoto","year":"2017","unstructured":"Sunyoto T, Potet J, Boelaert M. Visceral leishmaniasis in Somalia: a review of epidemiology and access to care. PLoS Negl Trop Dis. 2017;11:e0005231. https:\/\/doi.org\/10.1371\/journal.pntd.0005231.","journal-title":"PLoS Negl Trop Dis"},{"key":"6796_CR7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/cid\/cix245","volume":"65","author":"R Molina","year":"2017","unstructured":"Molina R, Ghosh D, Carrillo E, Monnerat S, Bern C, Mondal D, et\u00a0al. Infectivity of post-kala-azar dermal leishmaniasis patients to sand flies: revisiting a proof of concept in the context of the kala-azar elimination program in the Indian subcontinent. Clin Infect Dis. 2017;65:150\u20133. https:\/\/doi.org\/10.1093\/cid\/cix245.","journal-title":"Clin Infect Dis"},{"key":"6796_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40249-024-01204-5","volume":"13","author":"R Rocha","year":"2024","unstructured":"Rocha R, Concei\u00e7\u00e3o C, Gon\u00e7alves L, Maia C, LeishPT group. Epidemiological and clinical trends of visceral leishmaniasis in Portugal: retrospective analysis of cases diagnosed in public hospitals between 2010 and 2020. Infect Dis Poverty. 2024;13:41. https:\/\/doi.org\/10.1186\/s40249-024-01204-5.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010471","volume":"16","author":"S Mohan","year":"2022","unstructured":"Mohan S, Revill P, Malvolti S, Malhame M, Sculpher M, Kaye PM. Estimating the global demand curve for a leishmaniasis vaccine: a generalisable approach based on global burden of disease estimates. PLoS Negl Trop Dis. 2022;16:e0010471. https:\/\/doi.org\/10.1371\/journal.pntd.0010471.","journal-title":"PLoS Negl Trop Dis"},{"key":"6796_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00281-020-00788-y","volume":"42","author":"PM Kaye","year":"2020","unstructured":"Kaye PM, Cruz I, Picado A, Van Bocxlaer K, Croft SL. Leishmaniasis immunopathology-Impact on design and use of vaccines, diagnostics and drugs. Semin Immunopathol. 2020;42:247\u201364. https:\/\/doi.org\/10.1007\/s00281-020-00788-y.","journal-title":"Semin Immunopathol"},{"key":"6796_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1186\/s13071-018-3166-0","volume":"11","author":"ICM da Rocha","year":"2018","unstructured":"da Rocha ICM, Dos Santos LHM, Coura-Vital W, da Cunha GMR, Magalh\u00e3es FDC, da Silva TAM, et\u00a0al. Effectiveness of the Brazilian visceral leishmaniasis surveillance and control programme in reducing the prevalence and incidence of Leishmania infantum infection. Parasit Vectors. 2018;11:586. https:\/\/doi.org\/10.1186\/s13071-018-3166-0.","journal-title":"Parasit Vectors"},{"key":"6796_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006988","volume":"13","author":"E Diro","year":"2019","unstructured":"Diro E, Blesson S, Edwards T, Ritmeijer K, Fikre H, Admassu H, et\u00a0al. A randomized trial of Am Bisome monotherapy and Am Bisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia. PLoS Negl Trop Dis. 2019;13:e0006988. https:\/\/doi.org\/10.1371\/journal.pntd.0006988.","journal-title":"PLoS Negl Trop Dis"},{"key":"6796_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009990","volume":"15","author":"A Bouattour","year":"2021","unstructured":"Bouattour A, Amri A, Belkhiria JA, Rhim A, Fezaa O, Gantier JC, et\u00a0al. Canine leishmaniosis in Tunisia: growing prevalence, larger zones of infection. PLoS Negl Trop Dis. 2021;15:e0009990. https:\/\/doi.org\/10.1371\/journal.pntd.0009990.","journal-title":"PLoS Negl Trop Dis"},{"key":"6796_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009346","volume":"15","author":"ND Karunaweera","year":"2021","unstructured":"Karunaweera ND, Senanayake S, Ginige S, Silva H, Manamperi N, Samaranayake N, et\u00a0al. Spatiotemporal distribution of cutaneous leishmaniasis in Sri Lanka and future case burden estimates. PLoS Negl Trop Dis. 2021;15:e0009346. https:\/\/doi.org\/10.1371\/journal.pntd.0009346.","journal-title":"PLoS Negl Trop Dis"},{"key":"6796_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/tropicalmed7100258","volume":"7","author":"E Favi","year":"2022","unstructured":"Favi E, Santolamazza G, Botticelli F, Alfieri C, Delbue S, Cacciola R, et\u00a0al. Epidemiology, clinical characteristics, diagnostic work up, and treatment options of Leishmania infection in kidney transplant recipients: a systematic review. Trop Med Infect Dis. 2022;7:258. https:\/\/doi.org\/10.3390\/tropicalmed7100258.","journal-title":"Trop Med Infect Dis"},{"key":"6796_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1741-7015-7-54","volume":"7","author":"AB Joshi","year":"2009","unstructured":"Joshi AB, Das ML, Akhter S, Chowdhury R, Mondal D, Kumar V, et\u00a0al. Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal. BMC Med. 2009;7:54. https:\/\/doi.org\/10.1186\/1741-7015-7-54.","journal-title":"BMC Med"},{"key":"6796_CR17","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8.","journal-title":"Lancet"},{"key":"6796_CR18","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"GBD 2021 Demographics Collaborators","year":"2024","unstructured":"GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:1989\u20132056. https:\/\/doi.org\/10.1016\/S0140-6736(24)00476-8.","journal-title":"Lancet"},{"key":"6796_CR19","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"GBD 2021 Forecasting Collaborators","year":"2024","unstructured":"GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease study 2021. Lancet. 2024;403:2204\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(24)00685-8.","journal-title":"Lancet"},{"key":"6796_CR20","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease study 2021. Lancet. 2024;403:2162\u2013203. https:\/\/doi.org\/10.1016\/S0140-6736(24)00933-4.","journal-title":"Lancet"},{"key":"6796_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40249-024-01230-3","volume":"13","author":"SX Zhang","year":"2024","unstructured":"Zhang SX, Wang JC, Yang J, Lv S, Duan L, Lu Y, et\u00a0al. Epidemiological features and temporal trends of the co-infection between HIV and tuberculosis, 1990\u20132021: findings from the Global Burden of Disease study 2021. Infect Dis Poverty. 2024;13:59. https:\/\/doi.org\/10.1186\/s40249-024-01230-3.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2021.100021","volume":"1","author":"AR Freitas","year":"2021","unstructured":"Freitas AR, Beckedorff OA, de G\u00f3es Cavalcanti LP, Siqueira AM, de Castro DB, da Costa CF, et\u00a0al. The emergence of novel SARS-CoV-2 variant P.1 in Amazonas (Brazil) was temporally associated with a change in the age and sex profile of COVID-19 mortality: a population based ecological study. Lancet Reg Health Am. 2021;1:100021. https:\/\/doi.org\/10.1016\/j.lana.2021.100021.","journal-title":"Lancet Reg Health Am"},{"key":"6796_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102873","volume":"77","author":"Z Bai","year":"2024","unstructured":"Bai Z, Han J, An J, Wang H, Du X, Yang Z, et\u00a0al. The global, regional, and national patterns of change in the burden of congenital birth defects, 1990\u20132021: an analysis of the global burden of disease study 2021 and forecast to 2040. EClinicalMedicine. 2024;77:102873. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102873.","journal-title":"EClinicalMedicine"},{"key":"6796_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.soh.2024.100072","volume":"3","author":"Y Chen","year":"2024","unstructured":"Chen Y, Chen W, Cheng Z, Chen Y, Li M, Ma L, et\u00a0al. Global burden of HIV-negative multidrug- and extensively drug-resistant tuberculosis based on Global Burden of Disease study 2021. Sci One Health. 2024;3:100072. https:\/\/doi.org\/10.1016\/j.soh.2024.100072.","journal-title":"Sci One Health"},{"key":"6796_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40249-024-01265-6","volume":"13","author":"L Liu","year":"2024","unstructured":"Liu L, Lu LD, Yang GJ, Qian MB, Yang K, Tan F, et\u00a0al. Global, regional and national disease burden of food-borne trematodiases: projections to 2030 based on the Global Burden of Disease study 2021. Infect Dis Poverty. 2024;13:95. https:\/\/doi.org\/10.1186\/s40249-024-01265-6.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR26","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40249-024-01260-x","volume":"13","author":"YS Zhu","year":"2024","unstructured":"Zhu YS, Sun ZS, Zheng JX, Zhang SX, Yin JX, Zhao HQ, et\u00a0al. Prevalence and attributable health burdens of vector-borne parasitic infectious diseases of poverty, 1990\u20132021: findings from the Global Burden of Disease study 2021. Infect Dis Poverty. 2024;13:96. https:\/\/doi.org\/10.1186\/s40249-024-01260-x.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40249-024-01203-6","volume":"13","author":"LL Deng","year":"2024","unstructured":"Deng LL, Zhao F, Li ZW, Zhang WW, He GX, Ren X. Epidemiological characteristics of tuberculosis incidence and its macro-influence factors in Chinese mainland during 2014\u20132021. Infect Dis Poverty. 2024;13:34. https:\/\/doi.org\/10.1186\/s40249-024-01203-6.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s40249-023-01147-3","volume":"12","author":"LL Deng","year":"2023","unstructured":"Deng LL, Han YJ, Li ZW, Wang DY, Chen T, Ren X, et\u00a0al. Epidemiological characteristics of seven notifiable respiratory infectious diseases in the mainland of China: an analysis of national surveillance data from 2017 to 2021. Infect Dis Poverty. 2023;12:99. https:\/\/doi.org\/10.1186\/s40249-023-01147-3.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40249-024-01238-9","volume":"13","author":"J Chen","year":"2024","unstructured":"Chen J, Gong Y, Chen Q, Li S, Zhou Y. Global burden of soil-transmitted helminth infections, 1990\u20132021. Infect Dis Poverty. 2024;13:77. https:\/\/doi.org\/10.1186\/s40249-024-01238-9.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.soh.2024","volume":"3","author":"T Li","year":"2024","unstructured":"Li T, Qiang N, Bao Y, Li Y, Zhao S, Chong KC, et\u00a0al. Global burden of enteric infections related foodborne diseases, 1990\u20132021: findings from the Global Burden of Disease study 2021. Sci One Health. 2024;3:100075. https:\/\/doi.org\/10.1016\/j.soh.2024.","journal-title":"Sci One Health"},{"key":"6796_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40249-024-01252-x","volume":"13","author":"C Lv","year":"2024","unstructured":"Lv C, Chen Y, Cheng Z, Zhu Y, Chen W, Zhou N, et\u00a0al. Global burden of zoonotic infectious diseases of poverty, 1990\u20132021. Infect Dis Poverty. 2024;13:82. https:\/\/doi.org\/10.1186\/s40249-024-01252-x.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.soh.2024.100086","volume":"3","author":"C Chu","year":"2024","unstructured":"Chu C, Yang G, Yang J, Liang D, Liu R, Chen G, et\u00a0al. Trends in epidemiological characteristics and etiologies of diarrheal disease in children under five: an ecological study based on Global Burden of Disease study 2021. Sci One Health. 2024;3:100086. https:\/\/doi.org\/10.1016\/j.soh.2024.100086.","journal-title":"Sci One Health"},{"key":"6796_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000235","volume":"2","author":"I M\u00fcller","year":"2008","unstructured":"M\u00fcller I, Hailu A, Choi BS, Abebe T, Fuentes JM, Munder M, et\u00a0al. Age-related alteration of arginase activity impacts on severity of leishmaniasis. PLoS Negl Trop Dis. 2008;2:e235. https:\/\/doi.org\/10.1371\/journal.pntd.0000235.","journal-title":"PLoS Negl Trop Dis"},{"key":"6796_CR34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","volume":"377","author":"S Sundar","year":"2011","unstructured":"Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, et\u00a0al. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet. 2011;377:477\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(10)62050-8.","journal-title":"Lancet"},{"key":"6796_CR35","doi-asserted-by":"publisher","first-page":"e1763","DOI":"10.1016\/S2214-109X(21)00392-2","volume":"9","author":"J Alvar","year":"2021","unstructured":"Alvar J, den Boer M, Dagne DA. Towards the elimination of visceral leishmaniasis as a public health problem in east Africa: reflections on an enhanced control strategy and a call for action. Lancet Glob Health. 2021;9:e1763\u20139. https:\/\/doi.org\/10.1016\/S2214-109X(21)00392-2.","journal-title":"Lancet Glob Health"},{"key":"6796_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005889","volume":"11","author":"S Hirve","year":"2017","unstructured":"Hirve S, Kroeger A, Matlashewski G, Mondal D, Banjara MR, Das P, et\u00a0al. Towards elimination of visceral leishmaniasis in the Indian subcontinent-Translating research to practice to public health. PLoS Negl Trop Dis. 2017;11:e0005889. https:\/\/doi.org\/10.1371\/journal.pntd.0005889.","journal-title":"PLoS Negl Trop Dis"},{"key":"6796_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1475-2875-12-119","volume":"12","author":"AE Garley","year":"2013","unstructured":"Garley AE, Ivanovich E, Eckert E, Negroustoueva S, Ye Y. Gender differences in the use of insecticide-treated nets after a universal free distribution campaign in Kano State, Nigeria: post-campaign survey results. Malar J. 2013;12:119. https:\/\/doi.org\/10.1186\/1475-2875-12-119.","journal-title":"Malar J"},{"key":"6796_CR38","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392:951\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(18)31204-2.","journal-title":"Lancet"},{"key":"6796_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2023.102637","volume":"55","author":"A Poloni","year":"2023","unstructured":"Poloni A, Giacomelli A, Corbellino M, Grande R, Nebuloni M, Rizzardini G, et\u00a0al. Delayed diagnosis among patients with cutaneous and mucocutaneous leishmaniasis. Travel Med Infect Dis. 2023;55:102637. https:\/\/doi.org\/10.1016\/j.tmaid.2023.102637.","journal-title":"Travel Med Infect Dis"},{"key":"6796_CR40","doi-asserted-by":"publisher","first-page":"S301","DOI":"10.1093\/cid\/ciy007","volume":"66","author":"EA Le Rutte","year":"2018","unstructured":"Le Rutte EA, Chapman LAC, Coffeng LE, Ruiz-Postigo JA, Olliaro PL, Adams ER, et\u00a0al. Policy recommendations from transmission modeling for the elimination of visceral leishmaniasis in the Indian subcontinent. Clin Infect Dis. 2018;66:S301\u20138. https:\/\/doi.org\/10.1093\/cid\/ciy007.","journal-title":"Clin Infect Dis"},{"key":"6796_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40249-024-01198-0","volume":"13","author":"XX Zhang","year":"2024","unstructured":"Zhang XX, Lederman Z, Han LF, Schurer JM, Xiao LH, Zhang ZB, et\u00a0al. Towards an actionable One Health approach. Infect Dis Poverty. 2024;13:28. https:\/\/doi.org\/10.1186\/s40249-024-01198-0.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40249-024-01193-5","volume":"13","author":"J Obame-Nkoghe","year":"2024","unstructured":"Obame-Nkoghe J, Agossou AE, Mboowa G, Kamgang B, Caminade C, Duke DC, et\u00a0al. Climate-influenced vector-borne diseases in Africa: a call to empower the next generation of African researchers for sustainable solutions. Infect Dis Poverty. 2024;13:26. https:\/\/doi.org\/10.1186\/s40249-024-01193-5.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40249-022-00941-9","volume":"11","author":"R Zhang","year":"2022","unstructured":"Zhang R, Tang X, Liu J, Visbeck M, Guo H, Murray V, et\u00a0al. From concept to action: a united, holistic and One Health approach to respond to the climate change crisis. Infect Dis Poverty. 2022;11:17. https:\/\/doi.org\/10.1186\/s40249-022-00941-9.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40249-024-01240-1","volume":"13","author":"G Zhang","year":"2024","unstructured":"Zhang G, Qiu Y, Boireau P, Zhang Y, Ma X, Jiang H, et\u00a0al. Modern agriculture and One Health. Infect Dis Poverty. 2024;13:74. https:\/\/doi.org\/10.1186\/s40249-024-01240-1.","journal-title":"Infect Dis Poverty"},{"key":"6796_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.soh.2024.100067","volume":"3","author":"R Morris","year":"2024","unstructured":"Morris R, Wang S. Building a pathway to One Health surveillance and response in Asian countries. Sci One Health. 2024;3:100067. https:\/\/doi.org\/10.1016\/j.soh.2024.100067.","journal-title":"Sci One Health"},{"key":"6796_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.soh.2023.100039","volume":"2","author":"L Huang","year":"2023","unstructured":"Huang L, He J, Zhang C, Liu J, Guo Z, Lv S, et\u00a0al. China\u2019s One Health governance system: the framework and its application. Sci One Health. 2023;2:100039. https:\/\/doi.org\/10.1016\/j.soh.2023.100039.","journal-title":"Sci One Health"},{"key":"6796_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.soh.2023.100042","volume":"2","author":"ZY Guo","year":"2023","unstructured":"Guo ZY, Zheng J, Li SZ, Zhou XN. Orientation of One Health development: think globally and act locally. Sci One Health. 2023;2:100042. https:\/\/doi.org\/10.1016\/j.soh.2023.100042.","journal-title":"Sci One Health"},{"key":"6796_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.epidem.2017.01.002","volume":"18","author":"EA Le Rutte","year":"2017","unstructured":"Le Rutte EA, Chapman LA, Coffeng LE, Jervis S, Hasker EC, Dwivedi S, et\u00a0al. Elimination of visceral leishmaniasis in the Indian subcontinent: a comparison of predictions from three transmission models. Epidemics. 2017;18:67\u201380. https:\/\/doi.org\/10.1016\/j.epidem.2017.01.002.","journal-title":"Epidemics"},{"key":"6796_CR49","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/j.1365-3156.2008.02110.x","volume":"13","author":"B Ostyn","year":"2008","unstructured":"Ostyn B, Vanlerberghe V, Picado A, Dinesh DS, Sundar S, Chappuis F, et\u00a0al. Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? Trop Med Int Health. 2008;13:1073\u201385. https:\/\/doi.org\/10.1111\/j.1365-3156.2008.02110.x.","journal-title":"Trop Med Int Health"},{"key":"6796_CR50","doi-asserted-by":"publisher","first-page":"e304","DOI":"10.1016\/S1473-3099(16)30140-2","volume":"16","author":"OP Singh","year":"2016","unstructured":"Singh OP, Hasker E, Boelaert M, Sundar S. Elimination of visceral leishmaniasis on the Indian subcontinent. Lancet Infect Dis. 2016;16:e304\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(16)30140-2.","journal-title":"Lancet Infect Dis"},{"key":"6796_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.soh.2024.100098","volume":"4","author":"X Li","year":"2024","unstructured":"Li X, Zhang Y, Zhang Q, Liu J, Zhu Z, Feng X, et\u00a0al. Strategy and mechanism of One Health governance: case study of China. Sci One Health. 2024;4:100098. https:\/\/doi.org\/10.1016\/j.soh.2024.100098.","journal-title":"Sci One Health"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06796-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-06796-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-06796-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T08:32:24Z","timestamp":1747038744000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-025-06796-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6796"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-06796-x","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this study used publicly available summary data from GHDx health data, ethical approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}